D-9
NDC 58264-0009, Cupric acetate, Ipecac, Magnesium phosphate, Dibasic trihydrate, Drosera rotundifolia, Atropa belladonna, Hyoscyamus niger, Onion, Corallium rubrum exoskeleton, and Lobaria pulmonaria, solution, from DNA Labs, Inc..
- Product NDC
- 58264-0009
- Status
- Listed
- Labeler
- DNA Labs, Inc.
- Dosage form
- SOLUTION
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0009 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CUPRIC ACETATE6 [hp_X]/mL
- IPECAC6 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE30 [hp_X]/mL
- DROSERA ROTUNDIFOLIA6 [hp_X]/mL
- ATROPA BELLADONNA4 [hp_X]/mL
- HYOSCYAMUS NIGER4 [hp_X]/mL
- ONION4 [hp_X]/mL
- CORALLIUM RUBRUM EXOSKELETON12 [hp_X]/mL
- LOBARIA PULMONARIA4 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Non-Standardized Food Allergenic Extract [EPC]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Vegetable Proteins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58264-0009-1 | 58264000901 | 29.57 mL in 1 BOTTLE, GLASS (58264-0009-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58264-0009 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0009 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58264-0009. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.